Castillo Lucinda Villaescusa, García Francisco Zaragozá, Arnáez Cristina Zaragozá
Pharmacology Unit, Biomedical Sciences Department, Faculty of Pharmacy, University of Alcalá, 28871 Alcalá de Henares, Spain.
Plants (Basel). 2025 Jan 13;14(2):205. doi: 10.3390/plants14020205.
The genus (Asteraceae) has been traditionally used in Mediterranean medicine for its anti-inflammatory, antioxidant, and antimicrobial properties. However, scientific research on this genus remains limited, highlighting the need for a comprehensive review of its chemical composition and pharmacological characteristics. This review compiles existing knowledge on species, focusing on their secondary metabolites, such as flavonoids, terpenes, and essential oils, as well as associated biological activities. The findings show that the traditional therapeutic properties of are well supported by reported pharmacological activities in previous studies, emphasizing the potential of this genus for the development of new therapeutic agents. However, the lack of comparative studies among species and the scarcity of in vivo studies and clinical trials hinder the full realization of its therapeutic potential. Specifically, comparative studies could be key to identifying species with unique chemical profiles and understanding how variations in secondary metabolite composition may influence their pharmacological activities. This work highlights the urgent need to expand research in these areas to validate the pharmacological properties of species for their application in modern medicine.
菊科(Asteraceae)属传统上在地中海医学中因其抗炎、抗氧化和抗菌特性而被使用。然而,对该属的科学研究仍然有限,这凸显了对其化学成分和药理特性进行全面综述的必要性。本综述汇编了关于该属物种的现有知识,重点关注其次级代谢产物,如黄酮类化合物、萜类化合物和精油,以及相关的生物活性。研究结果表明,该属的传统治疗特性在先前研究报道的药理活性中得到了充分支持,强调了该属开发新治疗药物的潜力。然而,该属物种之间缺乏比较研究以及体内研究和临床试验的稀缺阻碍了其治疗潜力的充分实现。具体而言,比较研究可能是识别具有独特化学特征的物种以及了解次级代谢产物组成变化如何影响其药理活性的关键。这项工作强调了迫切需要扩大这些领域的研究,以验证该属物种在现代医学应用中的药理特性。